Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone + Ranibizumab vs Ranibizumab in nAMD
NCT01162746Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2011
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in neovascular age-related macular degeneration (NVAMD), sponsored by Medical University of Vienna. Started Oct 2011; status: completed.
02
Drugs
dexamethasone
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT01162746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01162746.